Table of Contents

1 Study Coverage

• 1.1 On-body Injectors Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global On-body Injectors Market Size Growth Rate by Product
  • 1.4.2 Electronical Injectors
  • 1.4.3 Mechanical Injectors
  • 1.4.4 Others
• 1.5 Market by End User
  • 1.5.1 Global On-body Injectors Market Size Growth Rate by End User
  • 1.5.2 Immuno-oncology
  • 1.5.3 Diabetes
  • 1.5.4 Cardiovascular Diseases
  • 1.5.5 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global On-body Injectors Market Size
  • 2.1.1 Global On-body Injectors Revenue 2014-2025
  • 2.1.2 Global On-body Injectors Sales 2014-2025
• 2.2 On-body Injectors Growth Rate by Regions
  • 2.2.1 Global On-body Injectors Sales by Regions
  • 2.2.2 Global On-body Injectors Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 On-body Injectors Sales by Manufacturers
  • 3.1.1 On-body Injectors Sales by Manufacturers
  • 3.1.2 On-body Injectors Sales Market Share by Manufacturers
  • 3.1.3 Global On-body Injectors Market Concentration Ratio (CR5 and HHI)
• 3.2 On-body Injectors Revenue by Manufacturers
  • 3.2.1 On-body Injectors Revenue by Manufacturers (2014-2019)
  • 3.2.2 On-body Injectors Revenue Share by Manufacturers (2014-2019)
• 3.3 On-body Injectors Price by Manufacturers
• 3.4 On-body Injectors Manufacturing Base Distribution, Product Types
  • 3.4.1 On-body Injectors Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers On-body Injectors Product Type
  • 3.4.3 Date of International Manufacturers Enter into On-body Injectors Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global On-body Injectors Sales by Product
• 4.2 Global On-body Injectors Revenue by Product
• 4.3 On-body Injectors Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global On-body Injectors Breakdown Data by End User

6 North America

• 6.1 North America On-body Injectors by Countries
  • 6.1.1 North America On-body Injectors Sales by Countries
  • 6.1.2 North America On-body Injectors Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America On-body Injectors by Product
• 6.3 North America On-body Injectors by End User

7 Europe

• 7.1 Europe On-body Injectors by Countries
  • 7.1.1 Europe On-body Injectors Sales by Countries
  • 7.1.2 Europe On-body Injectors Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe On-body Injectors by Product
• 7.3 Europe On-body Injectors by End User

8 Asia Pacific

• 8.1 Asia Pacific On-body Injectors by Countries
  • 8.1.1 Asia Pacific On-body Injectors Sales by Countries
  • 8.1.2 Asia Pacific On-body Injectors Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific On-body Injectors by Product
• 8.3 Asia Pacific On-body Injectors by End User

9 Central & South America

• 9.1 Central & South America On-body Injectors by Countries
  • 9.1.1 Central & South America On-body Injectors Sales by Countries
  • 9.1.2 Central & South America On-body Injectors Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America On-body Injectors by Product
• 9.3 Central & South America On-body Injectors by End User

10 Middle East and Africa

• 10.1 Middle East and Africa On-body Injectors by Countries
  • 10.1.1 Middle East and Africa On-body Injectors Sales by Countries
  • 10.1.2 Middle East and Africa On-body Injectors Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa On-body Injectors by Product
• 10.3 Middle East and Africa On-body Injectors by End User

11 Company Profiles

• 11.1 BD Medical
  • 11.1.1 BD Medical Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 BD Medical On-body Injectors Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 BD Medical On-body Injectors Products Offered
  • 11.1.5 BD Medical Recent Development
• 11.2 Medtronic
  • 11.2.1 Medtronic Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Medtronic On-body Injectors Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Medtronic On-body Injectors Products Offered
  • 11.2.5 Medtronic Recent Development
• 11.3 Insulet
  • 11.3.1 Insulet Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Insulet On-body Injectors Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Insulet On-body Injectors Products Offered
  • 11.3.5 Insulet Recent Development
• 11.4 Sensile Medical
  • 11.4.1 Sensile Medical Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Sensile Medical On-body Injectors Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Sensile Medical On-body Injectors Products Offered
  • 11.4.5 Sensile Medical Recent Development
• 11.5 Ypsomed
  • 11.5.1 Ypsomed Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Ypsomed On-body Injectors Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Ypsomed On-body Injectors Products Offered
  • 11.5.5 Ypsomed Recent Development
• 11.6 Enable Injections
  • 11.6.1 Enable Injections Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Enable Injections On-body Injectors Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Enable Injections On-body Injectors Products Offered
  • 11.6.5 Enable Injections Recent Development
• 11.7 Roche
  • 11.7.1 Roche Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Roche On-body Injectors Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Roche On-body Injectors Products Offered
  • 11.7.5 Roche Recent Development
• 11.8 ScPharmaceuticals
  • 11.8.1 ScPharmaceuticals Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 ScPharmaceuticals On-body Injectors Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 ScPharmaceuticals On-body Injectors Products Offered
  • 11.8.5 ScPharmaceuticals Recent Development
• 11.9 SteadyMed
  • 11.9.1 SteadyMed Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 SteadyMed On-body Injectors Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 SteadyMed On-body Injectors Products Offered
  • 11.9.5 SteadyMed Recent Development
• 11.10 CeQur
  • 11.10.1 CeQur Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 CeQur On-body Injectors Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 CeQur On-body Injectors Products Offered
  • 11.10.5 CeQur Recent Development
• 11.11 Tandem Diabetes Care
• 11.12 Valeritas
• 11.13 SteadyMed Therapeutics
• 11.14 Amgen

12 Future Forecast

• 12.1 On-body Injectors Market Forecast by Regions
  • 12.1.1 Global On-body Injectors Sales Forecast by Regions 2019-2025
  • 12.1.2 Global On-body Injectors Revenue Forecast by Regions 2019-2025
• 12.2 On-body Injectors Market Forecast by Product
  • 12.2.1 Global On-body Injectors Sales Forecast by Product 2019-2025
  • 12.2.2 Global On-body Injectors Revenue Forecast by Product 2019-2025
• 12.3 On-body Injectors Market Forecast by End User
• 12.4 North America On-body Injectors Forecast
• 12.5 Europe On-body Injectors Forecast
• 12.6 Asia Pacific On-body Injectors Forecast
• 12.7 Central & South America On-body Injectors Forecast
• 12.8 Middle East and Africa On-body Injectors Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 On-body Injectors Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

An on-body Injector is a small, lightweight delivery system applied to the skin.
The North American region is expected to account for the largest market share in 2018. The large share of this region can be attributed to the rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases and favorable reimbursement scenario in this region.
The global On-body Injectors market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the On-body Injectors market based on company, product type, end user and key regions.

This report studies the global market size of On-body Injectors in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of On-body Injectors in these regions.
This research report categorizes the global On-body Injectors market by top players/brands, region, type and end user. This report also studies the global On-body Injectors market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
BD Medical
Medtronic
Insulet
Sensile Medical
Ypsomed
Enable Injections
Roche
ScPharmaceuticals
SteadyMed
CeQur
Tandem Diabetes Care
Valeritas
SteadyMed Therapeutics
Amgen

Market size by Product
Electronical Injectors
Mechanical Injectors
Others
Market size by End User
Immuno-oncology
Diabetes
Cardiovascular Diseases
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global On-body Injectors market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of On-body Injectors market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global On-body Injectors companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of On-body Injectors submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of On-body Injectors are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of On-body Injectors market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.